Ironwood Pharmaceuticals (IRWD) Divestments (2010 - 2019)

Ironwood Pharmaceuticals (IRWD) reported Divestments of -$4.2 million for Q1 2019, down 38.6% sequentially from -$3.0 million in Q4 2018.

Ironwood Pharmaceuticals (IRWD) Divestments (2010 - 2019) Analysis & Trends

Ironwood Pharmaceuticals (IRWD) has 3 years of Divestments data on file, last reported at -$4.2 million in Q1 2019.

For the quarter ending Q1 2019, Divestments changed N/A year-over-year to -$4.2 million; the trailing twelve-month figure through Dec 2019 stood at -$4.2 million (up 35.19% YoY), and the FY2019 full-year result was -$4.2 million, up 48.94% from the prior year.
Divestments declined to -$4.2 million in Q1 2019, from -$3.0 million in the prior quarter.
In the past five years, Divestments ranged from a high of -$3.0 million in Q4 2018 to a low of -$4.2 million in Q1 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	42.00 Mn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	3.28 Mn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	63.20 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Ironwood Pharmaceuticals	619.48 Mn	399.01 Mn	-	-

Download Data